Hematology & Blood Cancer
Hematology & Blood Cancer
Advertisement
Cancer Nursing Today EditorsLeukemia | June 17, 2025
The program evaluated the practicality of independent pharmacists and nurses monitoring patients on a targeted-based regimen.
Read More
Cancer Nursing Today EditorsLeukemia | June 17, 2025
According to a team of researchers from China, family resilience could hold the key to boosting quality of life.
Cancer Nursing Today EditorsLeukemia | June 17, 2025
Understanding the relationship between caregiver burden and patient hope is essential, according to the researchers.
Cecilia BrownMultiple Myeloma | May 21, 2025
A series of semi-structured interviews revealed a “unique and burdensome” symptom experience among these patients.
Cecilia BrownMultiple Myeloma | May 21, 2025
The nurse-led team of researchers evaluated health information seeking behaviors across socioeconomic status groups.
Josie Montegaard, NPLeukemia | April 3, 2025
Josie Montegaard, NP, shares how nurses can help patients mitigate and manage negative CLL treatment side effects.
Laura LitwinConferences | June 10, 2025
Researchers analyzed clinical outcomes because hematopoietic SCT is becoming more a more accessible and utilized treatment.
Cecilia BrownConferences | June 10, 2025
Research presented at the NCCN Annual Conference illuminated patient experiences with tyrosine kinase inhibitors.
Laura LitwinConferences | June 10, 2025
Researchers assessed the cost effectiveness of ibrutinib, acalabrutinib, and zanubrutinib in multiple treatment settings.
Laura LitwinConferences | March 28, 2025
Researchers investigated underlying drivers of HRQOL degradation in CLL, including muscle weakness and fatigue.
Amy Pierre, RN, BSN, ANP-BCMultiple Myeloma | May 27, 2025
Amy Pierre, RN, BSN, ANP-BC, shares her insights on the importance of Multiple Myeloma Awareness Month.
Josie Montegaard, NPLeukemia | March 14, 2025
Josie Montegaard, NP, discusses key guidelines, criteria, and the need for flexibility when initiating treatment for CLL.
Laura LitwinGVHD | March 12, 2025
Previous research showed a potential connection between obesity and moderate to severe GVHD post-allogeneic SCT.
Stephen R. SpellmanConferences | March 6, 2025
Learn how ACCESS study data is informing patient-centered GVHD care and eliminating the donor access barrier for HSCT trials.
Josie Montegaard, NPLeukemia | February 28, 2025
Josie Montegaard, NP, shares how the right treatment timing and approach can influence quality of life for patients with CLL.
Teresa Hagan Thomas, PhD, RNHematology & Blood Cancer | May 21, 2025
The clinically focused intervention invovled a symptom assessment questionnaire followed by symptom support.
Laura LitwinConferences | March 7, 2025
Stephen R. Spellman shares highlights from the results of the ACCESS trial, which was presented at the 2025 Tandem Meetings.
Krystal Waldrup, BSN, RN, OCNConferences | June 18, 2025
Krystal Waldrup, BSN, RN, OCN, shares how the training improved nurse confidence and opened up capacity in the oncology unit.
Anna Barata, PhDHematology & Blood Cancer | February 14, 2025
Anna Barata, PhD, shares key insights from the CAR-T research that she presented during the 2025 Tandem Meetings.
Chelsea Honstain, NPConferences | February 12, 2025
Chelsea Honstain, NP, is vice chair of the APP Steering Committee and chair of the Education Subcommittee.
Advertisement
Advertisement